Skip to main content
. 2019 Mar 7;14:605–613. doi: 10.2147/COPD.S184695

Table 1.

General characteristics of the cohort at baseline by mortality

Characteristics Total (N=543) Mortality
P-value
Yes (n=167) No (n=376)

Gender (male) 522 (96.1) 165 (98.9) 357 (94.9) 0.032

Age (years): x¯(SD) 68.3 (8.3) 72.3 (6.4) 66.6 (8.5) <0.001

BMI (kg/m): x¯(SD) 28.3 (4.4) 27.9 (4.6) 28.4 (4.4) 0.252

Dyspnea (mMRC):x¯(SD) 24 (0.9) 1.37 (1.0) 2.2 (0.8) <0.001
 1 69 (12.7) 13 (7.8) 56 (14.9)
 2 264 (48.6) 60 (37.7) 201 (53.5)
 3 166 (30.6) 60 (35.9) 106 (28.2)
 4–5 44 (8.1) 31 (18.6) 13 (3.5)

FEV1 (mL): x¯(SD) 1,464 (441.3) 1,248 (368) 1,560 (438) <0.001

FEV1%: x¯(SD) 55.0 (13.3) 50.1 (13.7) 57.2 (12.6) <0.001

Smoking status
 Current smoker 114 (21.0) 24 (14.4) 90 (23.9) 0.02
 Former smoker 414 (76.2) 140 (83.8) 274 (72.9)
 No smoker 15 (2.8) 3 (1.8) 12 (3.2)

Packs/year: x¯(SD) 46.8 (27.3) 49.2 (27.5) 45.8 (27.2) 0.175

6-minute walking test (m): x¯(SD) 408.9 (92.4) 353.7 (99.8) 433.4 (77.3) <0.001

Hospital admission for COPD in the 2 previous years
 0 402 (74.0) 97 (58.1) 305 (81.1) <0.001
 1 87 (16.0) 40 (24.0) 47 (12.5)
 ≥2 54 (10.0) 30 (18.0) 24 (6.4)

Charlson comorbidity index: x¯(SD) 2.4 (1.4) 3.0 (1.7) 2.1 (1.2) <0.001
 0–1 172 (31.7) 33 (19.8) 139 (37.0)
 2–3 264 (48.6) 77 (46.1) 187 (49.7)
 >3 107 (19.7) 57 (34.1) 50 (13.3)

SGRQ (total): x¯(SD) 39.2 (20.1) 43.5 (19.6) 37.3 (20.0) <0.001

Coronary artery disease 32 (5.9) 18 (10.8) 14 (3.7) 0.001

Congestive heart failure 79 (14.6) 50 (29.9) 29 (7.7) <0.001

Angine 40 (7.4) 15 (9.0) 25 (6.6) 0.337

Arrhythmia 73 (13.4) 40 (24.0) 33 (8.8) <0.001

Valvular heart disease 17 (3.1) 10 (6.0) 7 (1.9) 0.011

Hypertension 211 (38.9) 76 (45.5) 135 (35.9) 0.034

Peripheral artery disease 49 (9.0) 21 (12.6) 28 (7.4) 0.054

Cerebrovascular accident 39 (7.2) 13 (7.8) 26 (6.9) 0.717

Diabetes 88 (16.2) 36 (21.6) 52 (13.8) 0.024

Chronic renal failure 8 (1.5) 6 (3.6) 2 (0.5) 0.006

Liver disease 36 (6.6) 18 (10.8) 18 (4.8) 0.009

Abbreviations: BMI, body mass index; SGRQ, St George’s Respiratory Questionnaire.